Quench Bio Inc, a start-up biotech incubated by venture capitalists, has been launched in Cambridge, Mass, US to develop small molecule drugs for chronic inflammatory and autoimmune diseases. The launch was announced on 27 January concurrent with $50 million in Series A financing.
